SAVA Cassava Sciences Inc Total Business Assets
Cassava Sciences, Inc. (SAVA) develops Alzheimer's disease treatments while minimizing chemical raw material supply disruptions to maintain high profitability. The historical price action of total assets reflects the value 176.75. The biopharmaceutical business is implementing ESG principles by investing in energy-efficient biomaterial storage and the safe disposal of reagents. Meanwhile, the financial model is based on the gradual drawdown of accumulated capital to fund the final stages of clinical trials.
Analytical breakdowns and data insights for company Cassava (SAVA)
- market value and analyst target forecast:
- market capitalization data:
- book capitalization information:
- debt burden and liquidity indicators:
All Debt to Shareholders' Equity Ratio Cassava Sciences, Inc.|SAVA - Long-Term Debt to Equity|Current Liabilities to Capital Cassava Pharma|SAVA - Company Aggregate Debts|Debt to Book Value Cassava Pharma|SAVA - Company Long-Term Debts|Company Short-Term Debts Cassava Sciences|Interim Coverage Ratio cassavasciences.com
- company profitability and valuation multiples indicators:
Fundamental valuation:SAVA, cassavasciences.com
Total assets represent the aggregate value of all company resources, calculated inversely via return on assets (ROA) to assess the fundamental capital base. By analyzing changes in financial assets, an investor can gauge the resource stability of Cassava Sciences, Inc. (SAVA), which is critical for a biotech firm whose development depends on long-term funding for clinical trials regardless of market cyclicality.
Direct competitors
biogen.com (BIIB) - Company Total Assets|Aggregate Company Assets Neurocrine Biosciences, Inc.|Total Business Assets RGC (Regencell Bioscience Ltd)|Company Total Assets AXSM|ACAD - Company Assets|Xenon Pharmaceuticals - Cumulative Company Assets|Company Total Assets vikingtherapeutics.com VKTX|SUPN - Aggregate Company Assets|Aggregate Asset Value CPRX (Catalyst Pharma)|Denali Therapeutics Inc (DNLI) - Aggregate Company Assets|Company Assets Harmony Corp (HRMY)|BHVN (Biohaven Ltd.) - Company Total Assets|Cumulative Company Assets amylyx.com (AMLX)|Company Total Assets TRVI|Company Total Assets Praxis Precision Medicines Inc (PRAX)|Aggregate Company Assets Anavex Corp AVXL|Company Total Asset Base CeriBell EEG (CBLL)|PRTA - Aggregate Company Assets|Company Total Asset Base Alector, Inc. ALEC|ANNX: Company Total Assets|Omeros (OMER) - Company Total Assets|Cumulative Company Assets NGNE|Aggregate Company Assets ACIU|Company Total Assets VYGR|Company Total Assets neumoratx.com (NMRA)|Scilex - Cumulative Company Assets|Aggregate Asset Value TVGN|ACOG - Aggregate Company Assets|Company Total Asset Base Cognition Therapeutics Inc. CGTX|IKT: Company Total Assets|Cumulative Company Assets Assertio|COYA (Coya Therapeutics Inc) - Company Total Assets|VistaGen Therapeutics Inc (VTGN) - Company Total Asset Base|Company Total Assets OVID|ABOS - Company Assets|Aggregate Company Assets CervoMed Inc. CRVO|ATHE: Total Business Assets|Clene Nanomedicine - Company Total Assets|PepGen Inc. (PEPG) - Cumulative Company Assets|JUNS: Company Total Assets|Company Assets Relmada Corp (RLMD)|Aggregate Company Assets Annovis Bio, Inc.|Grace Tx (GRCE) - Company Total Asset Base|Cumulative Company Assets AIFF (Firefly Neuroscience)|KLTO (anewmeds.com) - Aggregate Asset Value|Company Total Assets NRSN (NeuroSense Therapeutics Ltd.)|Company Total Asset Base Reviva Pharmaceuticals, Inc. (RVPH)|MTVA - Aggregate Company Assets|NRXS (neuraxis.com) - Total Business Assets|HSDT: Company Total Assets|Cumulative Company Assets Passage Bio|Cumulative Company Assets NEUP|Minerva (NERV) - Company Total Asset Base|Aggregate Company Assets Athira Pharma, Inc. (ATHA)|Company Total Asset Base addextherapeutics.com|Company Total Assets ALZN (Alzamend Neuro)|Company Total Assets Cyclerion Therapeutics Inc. CYCN|PTIX: Cumulative Company Assets|KTTA: Aggregate Company Assets|CRGT: Company Total Assets|avenuetx.com (ATXI) - Company Total Assets|Aggregate Company Assets BrainStorm Cell Therapeutics|Total Business Assets CARA (Cara Therapeutics Inc.)|Company Total Assets CHRO|ELYM - Company Assets|Intra-Cellular Therapies, Inc. - Cumulative Company Assets|Company Total Assets longboardpharma.com LBPH|MRNS - Aggregate Company Assets|Aggregate Asset Value NKGN (NKGen Biotech Inc)|NeuroBo (NRBO) - Aggregate Company Assets|Company Assets Sage Therapeutics Inc (SAGE)|SNPX (Synaptogenix, Inc.) - Company Total Assets|Cumulative Company Assets trevena.com (TRVN)|Company Total Assets VIGL|Company Total Assets anewmeds.com (WENA)|Aggregate Company Assets Cerevel CERE